Search

everythinglearnresearchcommunity

for

Search:↓

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

PCOS is a common and costly condition in North American women, causing various health issues like obesity, diabetes, and fertility problems.

δ-GABAA receptors affect alcohol consumption based on the estrous cycle and influence movement regardless of the cycle.

Astaxanthin may improve health by reducing inflammation, stress, and cholesterol, and by enhancing skin health and sports performance.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Ferroportin in macrophages is crucial for hair growth and skin healing by managing iron distribution.

Men with androgenetic alopecia (hair loss) are more likely to have fatty liver disease than those without hair loss.

Hepatitis C treatment may cause frontal fibrosing alopecia.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

Lipedematous alopecia causes permanent hair loss due to increased scalp fat.

Some overweight or obese men with long-term frontal fibrosing alopecia may have abnormal sex hormone levels.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

A rare skin condition in a baby showed unusual fat and hair follicle changes.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.

The Fas/FasL pathway may play a role in alopecia areata.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

AL136131.3 slows hair growth by affecting energy processes in hair loss.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

MFN2 mutations cause mitochondrial problems, unusual fat distribution, and low leptin despite high body fat.

Men with male pattern baldness have higher levels of A-FABP, which might help in early detection.

Fibrosing alopecia can be diagnosed without typical signs of lichen planopilaris.

Very-long-chain acyl-CoA synthetases and fatty acid transport proteins play key roles in fatty acid metabolism and lipid processing in different tissues.

FFA and FAPD might be related or stages of the same disease.

Fibrosing alopecia can be stabilized or improved with anti-inflammatory treatments and hair growth agents.

Nevus psiloliparus lacks mature hair follicles but keeps other skin structures intact.